• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Market Analysis

Connecting the Dots, Quantifying Technology Trends & Measuring Disruption

  • AI Market Analyzer
  • Tech News
    • Project Dashboard
  • Domain Marketplace
  • Sponsored Post
  • About
  • Contact

The U.S.’s blood supply had dipped to levels that the Red Cross has not seen in 10 years

January 10, 2022

The U.S.'s blood supply had dipped to levels that the Red Cross has not seen in 10 years. “This is the biggest challenge that I’ve seen in my 30 years in the business,” said Chris Hrouda, the president of biomedical services at the American Red Cross. https://t.co/9jtOLXQXo2

— The New York Times (@nytimes) December 25, 2021

Press Release
National Blood Shortage: Omicron Variant, Other Factors Decimate Blood Supply, More Donors Needed to Make Appointments Now

SAN FRANCISCO, Calif. (Jan. 10, 2022) — A national blood shortage is further stressing the nation’s fragile healthcare system. Vitalant, which services about 900 hospitals across 28 states, including 45 in the San Francisco Bay Area, currently is experiencing an historic, two-year low blood supply. The fast-spreading omicron variant is the latest COVID-19 complication forcing additional community blood drives to cancel and lessening the number of healthy and available donors.

“It’s important for people to remember that they can give blood immediately after receiving a COVID-19 vaccine if you’re healthy and well,” said Vitalant Chief Medical Officer Dr. Ralph Vassallo. “To ensure patient care isn’t jeopardized, we need people to schedule an appointment today. Even if the appointment is several weeks from now, setting and keeping it will help replenish what’s needed for both routine treatments and emergencies.”

Blood donations at Vitalant fell short of the need by more than 4,500 donations in December and the trend has continued into January. In addition to the effects of the omicron variant, severe winter weather in parts of the U.S. has further impacted blood drives, resulting in uncollected donations.

“Now is the time when new blood donors, those that haven’t given in a while and regular donors are all needed to step up and help address this critical healthcare issue,” said Cliff Numark, Vitalant senior vice president. “Astonishingly, only about 3% of the population donates blood, but most people are eligible. If more people start donating, shortages could be prevented.”

This shortage is not unique to Vitalant. Associations representing all blood services organizations in the U.S. warned the nation’s blood supply is at a dangerously low level and this trend must reverse to prevent hospitals from having to postpone potential lifesaving treatments.

Donors urged to act now: make an appointment
To make an appointment or for more information, visit vitalant.org or call 877-25-VITAL. Donors must feel well on the day of their donation. Like the COVID-19 vaccine, there’s no waiting period to donate for those who receive a seasonal flu vaccine if all other eligibility requirements are met.

About Vitalant
Vitalant (“Vye-TAL-ent”) is the nation’s largest independent, nonprofit blood services provider exclusively focused on providing lifesaving blood and comprehensive transfusion medicine services for about 900 hospitals and their patients across the U.S. Every day, Vitalant needs to collect about 5,300 blood, platelet and plasma donations to help save lives. For more information and to schedule a donation appointment, visit vitalant.org or call 877-25-VITAL (877-258-4825). Follow us on Facebook, Twitter and Instagram.

Filed Under: Reports Tagged With: alt blood, blood, blood surrogate, blood transfusion

Footer

Recent Posts

  • AI Market Analyzer Rises to 33.5 Cooling as CoreWeave Lifts Breadth and the Nvidia CEO Crisis Looms
  • AI Market Analyzer Slips to 30.4 Cooling as Chips Crash and Leveraged Bulls Keep Buying
  • Netlist (NLST) Revenue Jumps 149 Percent on Samsung License Cash as Silicon Labs (SLAB) Grows 22 Percent and QuickLogic (QUIK) Doubles
  • Omdia Says AI Software Revenue Will Top 200 Billion Dollars in 2026 as Generative AI Grows 139 Percent
  • Dell (DELL) Reports November 24 With a 95 Billion Dollar AI Backlog to Turn Into Cash as Supermicro (SMCI) Takes Its Record Quarter on the Road
  • CoreWeave (CRWV) Grows Revenue 168% to 3.66 Billion Dollars and Lifts Its Backlog to 132.5 Billion as the Neocloud Selloff Meets Real Numbers
  • Marvell vs Lumentum, Which AI Infrastructure Stock Is the Better Investment?
  • Lucid Grows Revenue 4% While the US EV Market Shrinks 41% and Adds 1.75 Billion Dollars of Saudi-Backed Credit to Reach Its Midsize Car
  • Entegris (ENTG) Targets 15 Percent Annual Growth and Onto Innovation (ONTO) Posts a Record Quarter as Chipmakers Struggle to Measure AI Returns
  • SovAI Joins NVIDIA Inception With Two Grid-Connected AI Factory Sites Built to the DSX Reference Design

RSS feed: Market Research Media Market Research Media

  • Four Vendor Surveys on Missed AI Returns Each Find the Problem Their Sponsor Sells a Fix For
  • Wasabi Study Puts Unplanned Infrastructure Spending at $63.4 Billion, With Germany Overspending by 7.1 Billion Euros
  • CSC Survey Finds 88% of Private Capital GPs Spend Up to Half Their Finance Time Checking Administrator Work
  • Lenovo Survey Finds 80% of IT Leaders Tie AI Success to the Digital Workplace and Only 10% Have Redesigned It
  • Claude and ChatGPT Integrations Killed the Headless CMS Market
  • Survey Margin of Error Explained, What Plus or Minus 3 Points Covers and What It Leaves Out
  • Morgan Stanley Pulse Survey Finds Bearish Investor Sentiment Rising to 42 Percent as Inflation Fears Grow
  • A Stronger Week Across the Network, October 4–10, 2026
  • The Tariff Map Is Becoming an Industrial Policy Map—and the U.S. Economy Is Paying the Price
  • PC Shipments Fall 22.4% as Higher Component Costs Price Buyers Out

Media Partners

  • Analysis
  • Technology Conferences
  • OSINT
  • Defense Market
  • Cybersecurity Market
  • Event Calendar
  • Calendarial
  • Opinion
  • 3V
  • Media Presser
  • Exclusive Domains

Copyright © 2026 MarketAnalysis.com | Terms of Service | Privacy Policy | Supplier Disclaimer | The Website Coded and Designed by SoftDev Studio

Media Partners: Technologies | Photography | Referently

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT